StonvexLoading…
StonvexStonvexStonvexCore line items from CTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $52.87M | $44.76M | $45.24M | $42.19M |
Operating Income | $-2.81M | $-7.24M | $-16.67M | $-9.96M |
Net Income | $-2.40M | $-9.98M | $-17.80M | $-14.91M |
EPS (Diluted) | $-0.03 | $-0.18 | $-0.38 | $-0.55 |
Total Assets | $41.90M | $37.84M | $30.11M | $33.04M |
Total Liabilities | $6.15M | $17.66M | $17.16M | $15.51M |
Cash & Equivalents | $14.88M | $12.26M | $1.83M | $4.64M |
Free Cash Flow OCF − CapEx | $-2.10M | $1.12M | $-2.28M | $900.88K |
Shares Outstanding | 94.61M | 77.08M | 47.67M | 41.70M |